Grindr Inc. is acquiring telehealth platform PurposeMed Inc. in a $250 million deal, Grindr announced on Wednesday.
This is Grindr’s first major acquisition since the West Hollywood-based company was founded in 2009. The acquisition deal is made up of about $190 million in cash and $60 million in common Grindr stock. The deal may include another $70 million in cash consideration that is dependent on reaching specific performance targets in 2027 and will then be paid out in 2028. Grindr’s acquisition of PurposeMed is expected to close by the end of the fourth business quarter this year.
“Grindr has a direct line to millions of gay men, and Freddie brings the medical expertise to turn that reach into care,” George Arison, Grindr’s chief executive and chair, said in a statement. “Together, we can revolutionize access to HIV prevention, just as Grindr revolutionized how gay men meet, and accelerate progress toward ending the HIV epidemic.”
The move is part of Grindr’s larger strategy to move beyond its dating app confines and become a larger platform of resources for the gay community – including healthcare needs. PurposeMed Inc., a Canada-based healthcare platform, is the parent company of HIV prevention and PrEP provider Freddie.
Freddie is expected to end 2026 with $80 million in revenue, per the company announcement.
“No one reaches the Freddie community like Grindr does,” Husein Moloo, co-founder and chief executive of Freddie and PurposeMed, said in a statement. “Together, we can bring that care to millions more people, inside the app they already use every day, and speed up the work of ending the HIV epidemic.”
Shifting business strategies
Grindr – which last year fended off a take-private deal advanced by then-board members James Fu Bin Lu and George Raymond Zage III, who have since resigned – has spent the last two years homing in on its expansion. Once a first mover in smartphone-based dating apps, and the first to cater to gay men, the company has since broadened its product roadmap to include travel guides and, as of recently, healthcare offerings. In 2025, Grindr unveiled Woodwork, its in-house healthcare platform for queer patients. The platform offers erectile dysfunction medications, GLP-1 drugs and peptide therapy.
The company’s expansion comes from the 17 years of data Grindr has amassed on how users spend their time on the platform, whether it’s to find friends, relationships or queer-friendly neighborhoods in the cities they’re traveling to.
“We started as a dating app for casual dating. But now our users use it for dating, to make friends, to make companions when they travel,” AJ Balance, Grindr’s chief product officer, told the Los Angeles Business Journal in 2025. “Because users are seeking casual connections, long-term relationships, travel tips, ways to meet up with people when they’re exploring your city or traveling in other cities, we are building a set of features across those different use cases.”
